Advertisement
Advertisement
Trending on Urology Times
1
FDA approves gepotidacin for uncomplicated urogenital gonorrhea
2
How urology can boost confidence and access for incontinence care
3
Identifying Real-World Evidence Gaps in mCSPC Care
4
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
5
